Experience
MannKind to Acquire scPharmaceuticals for up to $360 Million
August 25, 2025
Cooley advised MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products and delivery devices for patients with endocrine and orphan lung diseases, on its definitive merger agreement to acquire scPharmaceuticals for up to $360 million
Related contacts
Barbara Borden
Senior Counsel, San Diego
Rowook Park
Partner, San Diego
Julia Kim
Special Counsel, New York
Mischi a Marca
Partner, San Francisco
Adam J. Longenbach
Partner, New York
Matthew S. Scarano
Associate, San Diego
Megan Browdie
Partner, Washington, DC
Ross Eberly
Partner, Santa Monica
Todd Gluth
Partner, San Diego
Eric Greig
Partner, Washington, DC
Asa Henin
Partner, San Diego
Phil Mitchell
Partner, New York
Alessandra Murata
Partner, Palo Alto
Stella Sarma
Partner, Brussels
Charity Williams
Partner, San Diego
Julia R. Brinton
Special Counsel, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Emily Mason
Special Counsel, Santa Monica
Randy Sabett
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
David Dalton
Associate, Santa Monica
Sharon Davidov
Associate, New York
Jameson Davis
Associate, Boston
Athina Gaki
Associate, Brussels
Tony P. Guan
Associate, Santa Monica
Josh Himmelstern
Associate, San Diego
Michelle Hunt
Associate
Wyatt Kernell
Associate, Colorado
Bomin Kim
Associate, New York
Allison Kutner
Associate, New York
Jacob R. Lahana
Associate, Santa Monica
Eileen Leman
Associate, Los Angeles
Walter Musgrave
Associate, San Diego
Joseph Perry
Associate, Reston
Allie Pilmer
Associate, San Diego
Breanna Qin
Associate, Palo Alto
Vittoria Rainone
Associate, San Diego
Bartholomäus Regenhardt
Associate, Brussels
Brittany K. Wightman
Associate, San Diego
Jennifer Fitzpatrick
Paralegal Specialist, Washington, DC
Related Practices & Industries
Cooley Advises Investor Syndicate on $2.25 Billion Acquisition of HistoSonics
August 7, 2025
Cooley advised a syndicate of globally recognized private and public investors in connection with the management-led majority stake acquisition of HistoSonics, the developer of the Edison Histotripsy System and novel histotripsy therapy platform, valuing the company at approximately $2.25 billion.
Related contacts
Patrick Loofbourrow
Partner, Singapore
Bram G. Couvreur
Partner, Santa Monica
Rama Padmanabhan
Partner, San Diego
Jenny Ge
Associate, Santa Monica
Nick Kenyon
Associate, Boston
Josh Himmelstern
Associate, San Diego
Joanna Zhang
Associate, San Diego
Megan Browdie
Partner, Washington, DC
Sharon Connaughton
Special Counsel, Washington, DC
Stephanie Gentile
Partner, New York
Alessandra Murata
Partner, Palo Alto
Mark Cornillez-Ty
Associate, Los Angeles
Michael Pelle
Associate, New York
Orion Armon
Partner, Colorado
Alexis Finkelberg Bortniker
Partner, San Diego
Ross Eberly
Partner, Santa Monica
Charles Haley
Partner, Palo Alto
Joanna Liebes Hubberts
Partner, San Diego
Christopher Kimball
Partner, Washington, DC
John Paul Oleksiuk
Partner, New York
Stella Sarma
Partner, Brussels
Ellie Seber
Partner, Santa Monica
Erin Trenda
Partner, San Diego
Charity Williams
Partner, San Diego
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Bryan Berman
Special Counsel, Colorado
Andrew Epstein
Special Counsel, Seattle
Robert Jacques
Special Counsel, Washington, DC
Christian Lee
Special Counsel, San Francisco
Son Nguyen
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Stefan Cohen
Associate, New York
Sharon Davidov
Associate, New York
Jameson Davis
Associate, Boston
Michael Fernando
Associate, London
Allison Kutner
Associate, New York
Alexandra Leavy
Associate, New York
Eileen Leman
Associate, Los Angeles
Sunny J. Levine
Associate, Colorado
Edward (Teddy) Nimetz
Associate, New York
Emma Plankey
Associate, Boston
Breanna Qin
Associate, Palo Alto
Shu-en Wee
Associate, Singapore
Asal Yunusov
Associate, New York
Lisa Amii
Patent Agent, Palo Alto
Anna Anderson
Paralegal Specialist, London
Patricia Myers
Paralegal Specialist, Colorado
Gayana Stokes
Senior Paralegal, Washington, DC
Katie Kissner
Quantitative Analyst, San Francisco
Daniel Grooms
Partner, Washington, DC
Related Practices & Industries
Cooley Advises Special Committee of Checkpoint on Acquisition by Sun Pharma
March 9, 2025
Cooley advised the special committee of Checkpoint Therapeutics’ (Nasdaq: CKPT) board of directors in connection with Checkpoint’s definitive agreement to be acquired by Sun Pharmaceutical Industries (NSE: SUNPHARMA) for up to $416 million in cash and contingent value rights.
Related contacts
Bill Roegge
Partner, New York
Kevin Cooper
Partner, New York
Marc Recht
Partner, Boston
Wesley Dietrich
Associate, Washington, DC
Kathryn Benvenuti
Associate, New York
Michael Bergmann
Partner, Washington, DC
Eileen Marshall
Partner, Washington, DC
Alan W. Tamarelli
Partner, New York
Julia R. Brinton
Special Counsel, Washington, DC
Rebecca Ross
Special Counsel, Washington, DC
Stella Sarma
Partner, Brussels
Natasha Leskovsek
Of Counsel, Washington, DC
Karun Ahuja
Special Counsel, Chicago
Matthew Choy
Associate, New York
Jameson Davis
Associate, Boston
Kyle Hess
Associate, New York
Allison Kutner
Associate, New York
Breanna Qin
Associate, Palo Alto
Arda Can Tekin
Associate, London
Ryan Vann
Partner, Chicago
Related Practices & Industries
Nuvation Bio Announces up to $250 Million Nondilutive Financings From Sagard Healthcare Partners
February 18, 2025
Cooley advised Nuvation Bio (NYSE: NUVB), a global biopharmaceutical company tackling some of the greatest unmet needs in oncology, on its nondilutive financings of up to $250 million with Sagard Healthcare Partners.
Related contacts
Mischi a Marca
Partner, San Francisco
Addison Pierce
Partner, Chicago
Shimeng Cheng
Special Counsel, San Francisco
Kenneth Guernsey
Senior Counsel , San Francisco
Charles A. Watkins II
Associate, Santa Monica
Dr. Jon Cousin
Partner, Washington, DC
Christophe Beauduin
Partner, New York
Sonia Nath
Partner, Washington, DC
Aaron Pomeroy
Partner, Colorado
Eileen Marshall
Partner, Washington, DC
Michael Neumeister
Partner, Los Angeles
Francis Wheeler
Senior Counsel, Colorado
Stacey A. Bradford
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Melissa H. Boyd
Associate, San Francisco
Cara Buchicchio
Associate, New York
Jameson Davis
Associate, Boston
Auguste Humphries
Associate, Washington, DC
Rick Jantz
Associate, Santa Monica
Allison Kutner
Associate, New York
Shelby Saunders
Associate, New York
Dr. Jason Valentine
Associate, Washington, DC
Jennifer Fitzpatrick
Paralegal Specialist, Washington, DC
Yiming Liu
Partner in Charge – Shanghai, Shanghai
Related Practices & Industries
InnoCare and KeyMed Jointly Announce License Agreement With Prolium
January 20, 2025
Cooley represented Beijing Tiannuo Jiancheng Pharmaceutical Technology, a joint venture of a subsidiary of InnoCare Pharma (HKEX: 09969; SSE: 688428) and a subsidiary of KeyMed Biosciences (HKEX: 02162), in connection with a joint exclusive license agreement with Prolium Bioscience for the development and commercialization of ICP-B02 (CM355), a CD20xCD3 bispecific antibody.
Related contacts
Lila Hope
Partner, Palo Alto
Freddy Yip
Associate, Hong Kong
Michael Shen
Special Counsel, Shanghai
Ivy Wang
Associate, Shanghai
Letian Wei
Legal Consultant, Shanghai
Jameson Davis
Associate, Boston
Robert Eisenbach
Of Counsel, San Francisco
Xander Lee
Partner, Santa Monica
Bin Wang
Special Counsel, Palo Alto
Monica Xu
Special Counsel, Shanghai
Related Practices & Industries
Related news and events
Press Release
Cooley Advises Investor Syndicate on $2.25 Billion Acquisition of HistoSonics
August 7, 2025
Press Release
Cooley Advises Special Committee of Checkpoint on Acquisition by Sun Pharma
March 9, 2025
Admissions and credentials
California
Massachusetts
Not admitted to practice in Michigan